-Member Login

Forgot your USERNAME OR PASSWORD?

Let's Stay Connected

Find us on the popular social networks

Facebook Twitter LinkedIn Flicker
  • About the Division

    The Division for Cancer Pharmacology (DCP) serves members with interests in all aspects of basic and translational cancer pharmacology research. Specific areas include, (but are not limited to) discovery and preclinical development of new anticancer agents, preclinical toxicology and adverse reactions to anticancer drugs, technical developments in novel cancer-related target and therapeutic identification, mechanisms of anticancer drug resistance, mechanistic studies of novel therapeutic regimens, pharmacogenetics of anticancer therapeutics, and biomarker studies in anticancer drug response.

     


    Division News

  • Letter from the Executive Committee

    We write to alert you to activities of the Division for Cancer Pharmacology (DCP), a new member division of The American Society for Pharmacology and Experimental Therapeutics (ASPET) and, if you haven’t already done so, to encourage you and other colleagues to join ASPET and the new cancer pharmacology division.

    Division for Cancer Pharmacology Fall 2016 Newsletter

    The Fall 2016 edition of the Division for Cancer Pharmacology Newsletter is now available. View it now in PDF.  

    2016 Cancer Pharmacology Award Winners

    Congratulations to the winners of the 2016 best presentation competition (poster session) at EB2016.

    Division Meetings and Activities

    The ASPET Annual Meeting site has all the details on division meetings and activities, including the business meeting for each division. Agendas are now available for download for the business meetings.

    2016 Division for Cancer Pharmacology Election Results

    Dr. Mary-Ann Bjornsti, Professor and Chair, Department of Pharmacology and Toxicology, University of Alabama at Birmingham; Newman H. Waters Chair of Clinical Pharmacology; Associate Director for Translational Research, UAB Comprehensive Cancer Center has been elected chair-elect of the division. Dr. Jack C. Yalowich, Professor and Chair, Division of Pharmacology, The Ohio State University College of Pharmacy has been elected secretary/treasurer-elect of the division.

  • Right Rail DCP   
  • Division Goals

     

    • To increase outreach efforts with the goal of increasing membership from both academia and industry and their participation in ASPET meetings
    •  
    • To develop networking strategies for the benefit of junior and senior investigators
    •  
    • To increasing participation of industry-associated members in development of symposia for EB
    •  
    • To develop programming ideas including workshops addressing current challenges in cancer pharmacology (e.g. reproducibility and relevance of animal models of cancer)